ReSearch Pharma acquires Paramax
ReSearch Pharmaceutical Services (RPS), a Delaware-based provider of clinical solutions to the bio-pharmaceutical industry, has acquired medical research organisation Paramax International for $1 million (£700,000) in cash.
News